Form4insider filings, from the source

SEC Form 4 · accession 0001214659-15-002044

Teligent, Inc. · TLGT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
James C Gale
Director
Period of report
Mar 5, 2015
Accepted (ET)
Mar 6, 2015 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000352998

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 5, 2015S303,680$9.95D1,494,873D
Common StockF2Mar 5, 2015S1,696,320$9.95D8,356,988D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

This is a joint filing by Life Sciences Opportunities Fund (Institutional) II, L.P., Life Sciences Opportunities Fund II, L.P., the General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir. Life Sciences Opportunities Fund II, L.P. is the designated filer for Life Sciences Opportunities Fund (Institutional) II, L.P., the General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir. The address of each filer is the same as the designated filer except SMW, Mr. Sanders, Mr. Morris, and Mr. Weir, which is 600 Travis, Suite 5900, Houston, Texas 77002. Mr. Gale currently serves on the IGI Laboratories, Inc. board of directors.